ULTA
Bearish signalScored 2026-09-25 Drivers: Congress, trend, fundamentals. Moteurs : Congrès, tendance, fondamentaux.
Research, not advice.
À propos
Ulta Beauty, Inc.
- Nom
- Ulta Beauty, Inc.
- Secteur
- Consumer Cyclical
- Industrie
- Specialty Retail
- Bourse
- NASDAQ
- Capitalisation
- $26.7B
- Employés
- 65,000
- PDG
- Kecia L. Steelman
- Site web
- https://www.ulta.com
- Marché
- BBWICOTYELFIPARNYKAA.NSSBH
Ulta Beauty, Inc. functions as a prominent beauty product retailer throughout the United States. Its physical locations feature a broad assortment of goods, including cosmetics, perfumes, skincare, haircare items, bath and body essentials, and professional salon styling instruments. Additionally, they provide a comprehensive suite of salon services, encompassing hair, skin, makeup, brow, and nail treatments. The company further offers its proprietary label products, such as the Ulta Beauty Collection for cosmetics, skincare, and bath items, alongside other Ulta Beauty branded merchandise and gift options. As of March 10, 2022, Ulta Beauty operated 1,308 retail stores across all 50 U.S. states. Its products are also available for purchase via its website, ulta.com, and through its mobile applications. Incorporated in 1990, the enterprise was initially known as Ulta Salon, Cosmetics & Fragrance, Inc., before officially changing its name to Ulta Beauty, Inc. in January 2017. Its corporate base is located in Bolingbrook, Illinois.
Price (1 year)
Live chart from TradingView — independent market data, as price context around the filings, not the Quorum score. EMA 50/200 and Bollinger load by default. When the exchange is known it is sent as EXCHANGE:SYMBOL; otherwise TradingView resolves the ticker best-effort.
VENTE TOTALE: 600 titres (~322 387,56 $ US)
- Insiders
- Nagler Lorna
- Total bought
-
—
Avg buy (VWAP, 90d window) —
- Total sold
-
$1,414,153
Avg sell (VWAP, 90d window) $543.91 vs last close $547.89 (+0.7%)
Total sold sums Form 4 code S in this window. Codes F, M, A and G are left out.
- Last activity
- 2026-09-11
- Liquidity
- Liquid $296,035,788/day · 20d vol
- Last synced
-
2026-09-29 21:11:07
Sign in to request a sync of this company's price history and timing levels.
Insider holdings as a share of total assets aren't available for this company.
Avg buy and avg sell are volume-weighted prices (sum of shares × price, divided by shares) for Form 4 rows in this 90-day window that report both figures. A comparison with last close is market context for that average, not advice.
Recent Form 4
Filings in the 90-day window for this company. Value is shares × price from the filing. Research, not advice.
| Date | Person | Side | Shares | Price | Value | Form 4 |
|---|---|---|---|---|---|---|
| 2026-09-17 | Steelman Kecia | Sell · S S | 2,000 | $545.88 | ≈ $1,091,766 | Form 4 |
| 2026-09-11 | Nagler Lorna | Sell · S S | 600 | $537.31 | ≈ $322,388 | Form 4 |
Congressional trades
STOCK Act disclosures (90-day window)
Amounts are STOCK Act brackets as disclosed. Quorum does not turn a bracket into an exact price or a midpoint.
Recent trades
| Date | Representative | Type | Amount |
|---|---|---|---|
| 2026-07-07 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2026-03-19 | Maria Elvira Salazar | Purchase | $15,001 - $50,000 |
| 2026-02-03 | Tony Wied | Sale | $15,001 - $50,000 |
| 2026-01-13 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2026-01-09 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2026-01-06 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2025-12-11 | Daniel Milton Newhouse | Sale (Partial) | $1,001 - $15,000 |
| 2025-10-14 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2025-09-23 | Val Hoyle | Sale (Full) | $1,001 - $15,000 |
| 2025-07-10 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2024-11-15 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2024-08-14 | Greg Landsman | Sale (Full) | $1,001 - $15,000 |
| 2024-05-29 | Greg Landsman | Purchase | $15,001 - $50,000 |
| 2024-01-10 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2023-11-13 | Michael Guest | Purchase | $1,001 - $15,000 |
| 2023-11-03 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2023-10-31 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2023-10-02 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2023-09-08 | Lois Frankel | Sale (Full) | $1,001 - $15,000 |
| 2023-08-29 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2023-07-28 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2023-03-24 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2023-03-17 | Daniel Milton Newhouse | Sale (Partial) | $1,001 - $15,000 |
| 2023-03-16 | Lois Frankel | Sale (Partial) | $1,001 - $15,000 |
| 2022-11-03 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-09-20 | Daniel Milton Newhouse | Sale (Partial) | $1,001 - $15,000 |
| 2022-08-23 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-08-05 | John R. Curtis | Sale (Full) | $1,001 - $15,000 |
| 2022-05-23 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2022-03-08 | Daniel Milton Newhouse | Purchase | $1,001 - $15,000 |
| 2022-01-21 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-01-11 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2021-11-08 | John R. Curtis | Purchase | $1,001 - $15,000 |
| 2020-06-23 | Susie Lee | Sale (Full) | $1,001 - $15,000 |
| 2020-05-08 | Susie Lee | Purchase | $1,001 - $15,000 |
| 2019-10-18 | Cheri Bustos | Sale (Full) | $15,001 - $50,000 |
| 2018-10-11 | Lamar Seeligson Smith | Sale (Partial) | $1,001 - $15,000 |
| 2018-08-22 | Brad Schneider | Sale (Full) | $100,001 - $250,000 |
| 2018-05-16 | Lois Frankel | Purchase | $1,001 - $15,000 |
| 2018-04-03 | Josh S. Gottheimer | Sale (Full) | $1,001 - $15,000 |
| 2017-10-18 | Josh S. Gottheimer | Sale (Partial) | $1,001 - $15,000 |
Signal
Bearish signalScored 2026-09-25 Drivers: Congress, trend, fundamentals. Moteurs : Congrès, tendance, fondamentaux.
The 0-100 score behind this signal and the full written analysis are part of Plus. See plans.
Bearish signal
Drivers: Congress, trend, fundamentals. Moteurs : Congrès, tendance, fondamentaux.
Factor checklist — research, not advice
A check leans with a bullish reading. A cross leans against it. A dash is unavailable or mixed.
- Insider Pulls against a bullish reading. Selling cluster — sale value, no purchase value
- Congress Pulls against a bullish reading. STOCK Act sale disclosures outnumber purchases
- Narrative Unavailable or mixed. Stored narrative reading is in the neutral band
- Timing Pulls against a bullish reading. Close is more than 0.5 ATR under stored support
- Financial indicators Supports a bullish reading. Current ratio 1.41 · operating margin 12%
Suggested stop 533.88, nearest stored support minus 0.5 ATR(2.6% under the last close). Reward/risk to the next stored resistance is 0.10. Wait — that reward/risk is under 2. Research, not advice. Not an order.
Market snapshot
Financial ratios
| Metric | Trend | 2026-01-31 | 2025-02-01 | 2024-02-03 | 2023-01-28 | 2022-01-29 |
|---|---|---|---|---|---|---|
| Gross Profit Margin | 39.1% | 38.8% | 39.1% | 39.6% | 39.0% | |
| Ebit Margin | 12.4% | 14.0% | 15.1% | 16.1% | 15.0% | |
| Ebitda Margin | 14.8% | 16.4% | 17.3% | 18.5% | 18.1% | |
| Operating Profit Margin | 12.5% | 14.0% | 15.0% | 16.2% | 14.5% | |
| Pretax Profit Margin | 12.4% | 14.0% | 15.1% | 16.1% | 15.0% | |
| Continuous Operations Profit Margin | 9.3% | 10.6% | 11.5% | 12.2% | 11.4% | |
| Net Profit Margin | 9.3% | 10.6% | 11.5% | 12.2% | 11.4% | |
| Bottom Line Profit Margin | 9.3% | 10.6% | 11.5% | 12.2% | 11.4% | |
| Current Ratio | 1.414 | 1.702 | 1.711 | 1.611 | 1.464 | |
| Quick Ratio | 0.433 | 0.596 | 0.660 | 0.658 | 0.502 | |
| Solvency Ratio | 0.347 | 0.418 | 0.448 | 0.435 | 0.388 | |
| Cash Ratio | 0.191 | 0.395 | 0.462 | 0.439 | 0.277 | |
| Price To Earnings Ratio | 25.170 | 16.201 | 19.302 | 20.921 | 19.836 | |
| Price To Earnings Growth Ratio | 22.868 | -5.732 | 2.321 | 0.622 | 0.041 | |
| Forward Price To Earnings Growth Ratio | 22.868 | -5.732 | 2.321 | 0.622 | 0.041 | |
| Price To Earnings Diluted Ratio | 25.248 | 16.265 | 19.413 | 21.061 | 19.957 | |
| Price To Earnings Diluted Growth Ratio | 21.326 | -6.136 | 2.307 | 0.628 | 0.042 | |
| Price To Book Ratio | 10.355 | 7.819 | 10.931 | 13.263 | 12.733 | |
| Price To Sales Ratio | 2.342 | 1.722 | 2.223 | 2.546 | 2.265 | |
| Price To Free Cash Flow Ratio | 27.182 | 20.180 | 23.934 | 22.220 | 22.038 | |
| Price To Operating Cash Flow Ratio | 19.317 | 14.535 | 16.877 | 17.540 | 18.456 | |
| Debt To Assets Ratio | 0.312 | 0.320 | 0.335 | 0.354 | 0.388 | |
| Debt To Equity Ratio | 0.778 | 0.773 | 0.838 | 0.971 | 1.203 | |
| Debt To Capital Ratio | 0.438 | 0.436 | 0.456 | 0.493 | 0.546 | |
| Long Term Debt To Capital Ratio | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Financial Leverage Ratio | 2.497 | 2.412 | 2.504 | 2.740 | 3.103 | |
| Working Capital Turnover Ratio | 11.427 | 9.306 | 10.161 | 11.662 | 9.113 | |
| Operating Cash Flow Ratio | 0.676 | 0.752 | 0.890 | 0.881 | 0.680 | |
| Operating Cash Flow Sales Ratio | 0.121 | 0.119 | 0.132 | 0.145 | 0.123 | |
| Free Cash Flow Operating Cash Flow Ratio | 0.711 | 0.720 | 0.705 | 0.789 | 0.837 | |
| Debt Service Coverage Ratio | 3.938 | 5.096 | 5.408 | 5.238 | 4.554 | |
| Interest Coverage Ratio | 866.711 | 0.000 | 0.000 | 0.000 | 752.004 | |
| Short Term Operating Cash Flow Coverage Ratio | 4.073 | 4.646 | 5.201 | 5.231 | 3.864 | |
| Operating Cash Flow Coverage Ratio | 0.689 | 0.696 | 0.772 | 0.779 | 0.574 | |
| Capital Expenditure Coverage Ratio | 3.456 | 3.575 | 3.392 | 4.748 | 6.152 | |
| Dividend Paid And Capex Coverage Ratio | 3.456 | 3.575 | 3.392 | 4.748 | 6.152 | |
| Dividend Payout Ratio | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Enterprise Value Multiple | 16.789 | 11.194 | 13.436 | 14.408 | 13.388 |
Sparkline shows each ratio oldest → newest (left → right).
How the latest year compares
For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower
| Metric | Current | vs 1Y ago | vs 5Y avg |
|---|---|---|---|
| Gross Profit Margin | 39.1% | ▲0.3% | ▼-0.0% |
| Ebit Margin | 12.4% | ▼-1.6% | ▼-2.1% |
| Ebitda Margin | 14.8% | ▼-1.6% | ▼-2.2% |
| Operating Profit Margin | 12.5% | ▼-1.5% | ▼-1.9% |
| Pretax Profit Margin | 12.4% | ▼-1.6% | ▼-2.2% |
| Continuous Operations Profit Margin | 9.3% | ▼-1.3% | ▼-1.7% |
| Net Profit Margin | 9.3% | ▼-1.3% | ▼-1.7% |
| Bottom Line Profit Margin | 9.3% | ▼-1.3% | ▼-1.7% |
| Current Ratio | 1.413 | ▼-0.289 | ▼-0.167 |
| Quick Ratio | 0.433 | ▼-0.163 | ▼-0.137 |
| Solvency Ratio | 0.347 | ▼-0.071 | ▼-0.061 |
| Cash Ratio | 0.191 | ▼-0.204 | ▼-0.162 |
| Price To Earnings Ratio | 25.169 | ▲8.969 | ▲4.884 |
| Price To Earnings Growth Ratio | 22.868 | ▲28.600 | ▲18.844 |
| Forward Price To Earnings Growth Ratio | 22.868 | ▲28.600 | ▲18.844 |
| Price To Earnings Diluted Ratio | 25.248 | ▲8.983 | ▲4.859 |
| Price To Earnings Diluted Growth Ratio | 21.326 | ▲27.462 | ▲17.693 |
| Price To Book Ratio | 10.355 | ▲2.536 | ▼-0.665 |
| Price To Sales Ratio | 2.342 | ▲0.620 | ▲0.123 |
| Price To Free Cash Flow Ratio | 27.182 | ▲7.002 | ▲4.071 |
| Price To Operating Cash Flow Ratio | 19.317 | ▲4.782 | ▲1.972 |
| Debt To Assets Ratio | 0.312 | ▼-0.009 | ▼-0.030 |
| Debt To Equity Ratio | 0.778 | ▲0.005 | ▼-0.134 |
| Debt To Capital Ratio | 0.438 | ▲0.002 | ▼-0.036 |
| Long Term Debt To Capital Ratio | 0.000 | 0.000 | 0.000 |
| Financial Leverage Ratio | 2.497 | ▲0.085 | ▼-0.154 |
| Working Capital Turnover Ratio | 11.427 | ▲2.121 | ▲1.093 |
| Operating Cash Flow Ratio | 0.676 | ▼-0.077 | ▼-0.100 |
| Operating Cash Flow Sales Ratio | 0.121 | ▲0.003 | ▼-0.007 |
| Free Cash Flow Operating Cash Flow Ratio | 0.711 | ▼-0.010 | ▼-0.042 |
| Debt Service Coverage Ratio | 3.938 | ▼-1.158 | ▼-0.909 |
| Interest Coverage Ratio | 866.711 | ▲866.711 | ▲542.968 |
| Short Term Operating Cash Flow Coverage Ratio | 4.073 | ▼-0.573 | ▼-0.530 |
| Operating Cash Flow Coverage Ratio | 0.689 | ▼-0.007 | ▼-0.013 |
| Capital Expenditure Coverage Ratio | 3.456 | ▼-0.119 | ▼-0.808 |
| Dividend Paid And Capex Coverage Ratio | 3.456 | ▼-0.119 | ▼-0.808 |
| Dividend Payout Ratio | 0.000 | 0.000 | 0.000 |
| Enterprise Value Multiple | 16.789 | ▲5.595 | ▲2.946 |
Key metrics
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Market cap | $29.03B | $19.46B | $24.91B | $25.99B | $19.55B | |
| Enterprise value | $30.79B | $20.68B | $26.06B | $27.16B | $20.96B | |
| EV / Sales | 2.48x | 1.83x | 2.33x | 2.66x | 2.43x | |
| EV / Op. cash flow | 20.49x | 15.45x | 17.65x | 18.33x | 19.79x | |
| EV / Free cash flow | 28.83x | 21.45x | 25.03x | 23.22x | 23.63x | |
| EV / EBITDA | 16.79x | 11.19x | 13.44x | 14.41x | 13.39x | |
| Net debt / EBITDA | 0.96x | 0.66x | 0.59x | 0.62x | 0.90x | |
| Current ratio | 1.41x | 1.70x | 1.71x | 1.61x | 1.46x | |
| Income quality | 1.30x | 1.11x | 1.14x | 1.19x | 1.07x | |
| Graham number | $190 | $174 | $165 | $144 | $107 | |
| Graham net-net | -$53 | -$35 | -$33 | -$33 | -$34 | |
| Tax burden | 75.3% | 76.0% | 76.1% | 75.6% | 76.1% | |
| Interest burden | 99.9% | 100.0% | 100.0% | 100.0% | 99.9% | |
| Working capital | $919.8M | $1.25B | $1.18B | $1.03B | $723.2M | |
| Invested capital | $4.60B | $4.11B | $3.95B | $3.61B | $3.13B | |
| Return on assets | 16.5% | 20.0% | 22.6% | 23.1% | 20.7% | |
| Operating ROA | 23.8% | 27.0% | 30.5% | 32.5% | 25.4% | |
| Return on tangible assets | 17.6% | 20.0% | 22.7% | 23.2% | 20.7% | |
| Return on equity | 41.1% | 48.3% | 56.6% | 63.4% | 64.2% | |
| Return on invested capital | 22.8% | 26.6% | 29.6% | 31.4% | 27.3% | |
| Return on capital employed | 32.4% | 37.4% | 41.7% | 44.7% | 39.0% | |
| Earnings yield | 4.0% | 6.2% | 5.2% | 4.8% | 5.0% | |
| Free cash flow yield | 3.7% | 5.0% | 4.2% | 4.5% | 4.5% | |
| Capex / Op. cash flow | 28.9% | 28.0% | 29.5% | 21.1% | 16.3% | |
| Capex / Depreciation | 144.6% | 140.2% | 178.5% | 129.3% | 64.1% | |
| Capex / Sales | 3.5% | 3.3% | 3.9% | 3.1% | 2.0% | |
| SG&A / Sales | 26.6% | 24.9% | 24.0% | 23.5% | 24.5% | |
| R&D / Sales | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| Stock comp / Sales | 0.3% | 0.4% | 0.4% | 0.4% | 0.5% | |
| Intangibles / Total assets | 6.1% | 0.2% | 0.2% | 0.2% | 0.3% | |
| Days sales outstanding | 9d | 7d | 7d | 7d | 10d | |
| Days payables outstanding | 33d | 30d | 29d | 33d | 38d | |
| Operating cycle | 114d | 111d | 100d | 102d | 114d | |
| Cash conversion cycle | 81d | 81d | 71d | 69d | 76d |
Change by theme
Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.
Change over 1 year
Valuation
Market cap ▲+49.2%EV / Sales ▲+35.7%EV / EBITDA ▲+50.0%EV / Op. cash flow ▲+5.040Earnings yield ▼-0.022Graham number ▲+16.507
Profitability
Return on equity ▼-0.071Return on assets ▼-0.035Return on invested capital ▼-0.038Return on capital employed ▼-0.050Operating ROA ▼-0.031Income quality ▲+0.188Tax burden ▼-0.007
Efficiency
Days sales outstanding ▲+1.508Days payables outstanding ▲+3.383Operating cycle ▲+2.997Cash conversion cycle ▼-0.386Capex / Sales ▲+0.002R&D / Sales n/a
Balance-sheet strength
Current ratio ▼-0.289Net debt / EBITDA ▲+0.298Working capital ▼-329526000.000Invested capital ▲+487080000.000Intangibles / Total assets ▲+0.060
Change over 5 years
Valuation
Market cap ▲+48.5%EV / Sales ▲+2.3%EV / EBITDA ▲+25.4%EV / Op. cash flow ▲+0.695Earnings yield ▼-0.011Graham number ▲+83.106
Profitability
Return on equity ▼-0.231Return on assets ▼-0.042Return on invested capital ▼-0.046Return on capital employed ▼-0.066Operating ROA ▼-0.016Income quality ▲+0.228Tax burden ▼-0.007
Efficiency
Days sales outstanding ▼-1.158Days payables outstanding ▼-5.168Operating cycle ▲+0.334Cash conversion cycle ▲+5.502Capex / Sales ▲+0.015R&D / Sales n/a
Balance-sheet strength
Current ratio ▼-0.051Net debt / EBITDA ▲+0.055Working capital ▲+196631000.000Invested capital ▲+1464336000.000Intangibles / Total assets ▲+0.059
Employee count
Peer market caps
Recent news
- 2026-09-16 Adagio Medical Highlights First Patient Treated in IDE Study Evaluating Next-Generation vCLAS™ Ultra System for Ventricular Tachycardia at Banner -- University Medical Center Phoenix Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (âAdagioâ or âthe Companyâ), a leading innovator in catheter ablation technologies for the treatment of car
- 2026-09-15 Why Ulta Beauty (ULTA) is a Top Momentum Stock for the Long-Term Whether you''re a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
- 2026-09-15 This Ulta Beauty Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Tuesday Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- 2026-09-15 Here Are Tuesday’s Top Wall Street Analyst Research Calls: Autodesk, Eli Lilly, Etsy, Lear, Netskope, Nokia, Northrop Grumman, Rapid7, Rivian Automotive, Ulta Beauty, and More Markets are rattled ahead of Wednesday''s Fed decision, and Wall Street analysts are making bold moves on names like Eli Lilly, Etsy, Northrop Grumman, and Rivian. Find out which stocks got upgraded, downgraded, or newly covered before the opening bell.
- 2026-09-13 Ulta Beauty Sees Resilient Demand, Eyes Fragrance, Wellness Growth After Target Exit Ulta Beauty NASDAQ: ULTA executives said the company is seeing continued resilience in consumer beauty spending, supported by its broad price range, loyalty program, stores, services and investments in technology.
- 2026-09-10 Ulta Beauty, Inc. (ULTA) Presents at Barclays 19th Annual Global Consumer Staples Conference Transcript Ulta Beauty, Inc. (ULTA) Presents at Barclays 19th Annual Global Consumer Staples Conference Transcript
- 2026-09-09 Here Are Tuesday’s Top Wall Street Analyst Research Calls: Abercrombie & Fitch, Affirm Holdings, Eagle Materials, Klarna Group, Martin Marietta Materials, Oklo, Qualcomm, Robinhood Markets, Ulta Beauty, and More Stocks took a beating Tuesday as surging oil prices and looming inflation data rattled every corner of the market, and now Wall Street analysts are reshuffling their calls on names ranging from nuclear energy upstart Oklo to retail giants Abercrombie and Ulta Beauty.
- 2026-09-09 Ulta Beauty Keeps Growing, But I Am Still Reluctant To Buy - And Here Are The Reasons Why Ulta Beauty beat earnings estimates and raised guidance, but I maintain a neutral rating due to underlying concerns. ULTA''s largest revenue segments—cosmetics and skincare & wellness—showed flat or declining performance, with overall comps growth barely above inflation. Comps growth is driven by e-commerce, while ongoing physical store expansion raises cost concerns and questions about long-term profitability.
- 2026-09-09 Ulta Beauty Inc. $ULTA Shares Purchased by California State Teachers Retirement System California State Teachers Retirement System increased its holdings in shares of Ulta Beauty Inc. (NASDAQ: ULTA) by 43,592.1% during the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 29,433,210 shares of the specialty retailer''s stock after buying an additional
- 2026-09-08 Walmart, Ulta and Other Retailers That Can Win With AI Walmart, Ulta Beauty, Costco, and BJ''s are among the retailers well positioned to benefit as artificial intelligence transforms shopping and operations, according to TD Cowen.